Staphylococcus aureus endocarditis: a consequence of medical progress.

By V. Fowler, J. Miró, B. Hoen, C. Cabell, E. Abrutyn, E. Rubinstein, G. Corey, D. Spelman, S. Bradley, B. Baršić and 11 more. Journal of the American Medical Association (JAMA), 2005

1,201 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases, Surgery

View Paper: https://www.semanticscholar.org/paper/945b33ead6e0c5fb2077c2ba2e0fe483a97f3a93

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Robert S. Daum
2. H. Boucher
3. G. Corey
4. P. O'Gara

In Infectious Diseases

1. D. Levine
2. Robert S. Daum
3. S. Cosgrove
4. H. Boucher
5. G. Corey
6. Henry F. Chambers

In Surgery

1. S. Cosgrove

Citations in the corpus

• Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America (2009, neutral): “aeruginosa, fungi, or mycobacteria A-II [144, 145]”
• Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. (2012, methodology): “aureus IE study by Fowler et al [6].”
• GUIDELINES ON THE PREVENTION, DIAGNOSIS, AND TREATMENT OF INFECTIVE ENDOCARDITIS (NEW VERSION 2009) (2010, neutral): “Degenerative valve lesions are detected by echocardiography in up to 50% of asymptomatic patients over 60 years,33 and in a similar proportion of elderly patients with IE.”
• Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association (2015, background): “vascular catheters, surgical wounds, indwelling prosthetic devices, hemodialysis)(6,8,9) and is especially prevalent in North America.(6,138,139) Increasing rates of oxacillin-resistant S aureus”
• Epidemiology of methicillin-resistant Staphylococcus aureus. (2008, background): “In addition, the medical issues of these infected patients have become more complex as a result of our sophisticated medical system [2, 12].”
• Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. (2011, background): “Evidence Summary MRSA bacteremia and infective endocarditis are serious diseases associated with high morbidity, and mortality rates are 30%– 37% for MRSA endocarditis [170, 171].”